Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Grant/Award of 30,000 GOSS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 30,000 | n/a |
| Aug 27, 2026 | REGENXBIO Inc. (RGNX) | Grant/Award | 15,432 | n/a |
| Jun 11, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 12,000 | n/a |
| Jan 13, 2026 | Zymeworks Inc. (ZYME) | Grant/Award | 11,500 | n/a |
| Aug 13, 2025 | Zymeworks Inc. (ZYME) | Grant/Award | 415,000 | $4.99M |
| May 16, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 75,572 | $499.5K |